Literature DB >> 26986800

Increases in NKG2C Expression on T Cells and Higher Levels of Circulating CD8+ B Cells Are Associated with Sterilizing Immunity Provided by a Live Attenuated SIV Vaccine.

Vida L Hodara1,2, Laura M Parodi1, M Shannon Keckler3, Luis D Giavedoni1,2.   

Abstract

Vaccines based on live attenuated viruses are highly effective immunogens in the simian immunodeficiency virus (SIV)/rhesus macaque animal model and offer the possibility of studying correlates of protection against infection with virulent virus. We utilized a tether system for studying, in naive macaques and animals vaccinated with a live-attenuated vaccine, the acute events after challenge with pathogenic SIV. This approach allowed for the frequent sampling of small blood volumes without sedation or restraining of the animals, thus reducing the confounding effect of sampling stress. Before challenge, vaccinated animals presented significantly higher levels of proliferating and activated B cells than naive macaques, which were manifested by high expression of CD8 on B cells. After SIV challenge, the only changes observed in protected vaccinated macaques were significant increases in expression of the NK marker NKG2C on CD4 and CD8 T cells. We also identified that infection of naive macaques with SIV resulted in a transient peak of expression of CD20 on CD8 T cells and a constant rise in the number of B cells expressing CD8. Finally, analysis of a larger cohort of vaccinated animals identified that, even when circulating levels of vaccine virus are below the limit of detection, live attenuated vaccines induce systemic increases of IP-10 and perforin. These studies indicate that components of both the innate and adaptive immune systems of animals inoculated with a live-attenuated SIV vaccine respond to and control infection with virulent virus. Persistence of the vaccine virus in tissues may explain the elevated cytokine and B-cell activation levels. In addition, our report underpins the utility of the tether system for the intensive study of acute immune responses to viral infections.

Entities:  

Keywords:  NKG2C; SIV; acute; challenge; cytokines; immunity; inflammation; lymphocytes; macaques; rhesus; sterilizing; vaccine

Mesh:

Substances:

Year:  2016        PMID: 26986800      PMCID: PMC5067875          DOI: 10.1089/aid.2015.0300

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  56 in total

1.  Preservation of functional virus-specific memory CD8+ T lymphocytes in vaccinated, simian human immunodeficiency virus-infected rhesus monkeys.

Authors:  Paula M Acierno; Jörn E Schmitz; Darci A Gorgone; Yue Sun; Sampa Santra; Michael S Seaman; Michael H Newberg; John R Mascola; Gary J Nabel; Dennis Panicali; Norman L Letvin
Journal:  J Immunol       Date:  2006-05-01       Impact factor: 5.422

2.  Activating CD94:NKG2C and inhibitory CD94:NKG2A receptors are expressed by distinct subsets of committed CD8+ TCR alphabeta lymphocytes.

Authors:  Lionel Arlettaz; Jean Villard; Casimir de Rham; Sylvie Degermann; Bernard Chapuis; Bertrand Huard; Eddy Roosnek
Journal:  Eur J Immunol       Date:  2004-12       Impact factor: 5.532

3.  Acute and chronic T cell dynamics in the livers of simian immunodeficiency virus-infected macaques.

Authors:  Muhammad H Ahsan; Amy F Gill; Andrew A Lackner; Ronald S Veazey
Journal:  J Virol       Date:  2012-02-29       Impact factor: 5.103

4.  A surgical procedure and tethering system for chronic blood sampling, infusion, and temperature monitoring in caged nonhuman primates.

Authors:  G A McNamee; R W Wannemacher; R E Dinterman; H Rozmiarek; R D Montrey
Journal:  Lab Anim Sci       Date:  1984-06

Review 5.  Immune response to HIV.

Authors:  Matthieu Perreau; Yves Levy; Giuseppe Pantaleo
Journal:  Curr Opin HIV AIDS       Date:  2013-07       Impact factor: 4.283

6.  Trivalent live attenuated influenza-simian immunodeficiency virus vaccines: efficacy and evolution of cytotoxic T lymphocyte escape in macaques.

Authors:  Jeanette C Reece; Sheilajen Alcantara; Shayarana Gooneratne; Sinthujan Jegaskanda; Thakshila Amaresena; Caroline S Fernandez; Karen Laurie; Aeron Hurt; Shelby L O'Connor; Max Harris; Janka Petravic; Alexey Martyushev; Andrew Grimm; Miles P Davenport; John Stambas; Robert De Rose; Stephen J Kent
Journal:  J Virol       Date:  2013-01-23       Impact factor: 5.103

7.  Distinct cycling CD4(+)- and CD8(+)-T-cell profiles during the asymptomatic phase of simian immunodeficiency virus SIVmac251 infection in rhesus macaques.

Authors:  V Monceaux; R Ho Tsong Fang; M C Cumont; B Hurtrel; J Estaquier
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

8.  Increased cellular immune responses and CD4+ T-cell proliferation correlate with reduced plasma viral load in SIV challenged recombinant simian varicella virus - simian immunodeficiency virus (rSVV-SIV) vaccinated rhesus macaques.

Authors:  Bapi Pahar; Wayne L Gray; Kimberly Phelps; Elizabeth S Didier; Eileen deHaro; Preston A Marx; Vicki L Traina-Dorge
Journal:  Virol J       Date:  2012-08-13       Impact factor: 4.099

9.  Early biodistribution and persistence of a protective live attenuated SIV vaccine elicits localised innate responses in multiple lymphoid tissues.

Authors:  Deborah Ferguson; Giada Mattiuzzo; Claire Ham; Richard Stebbings; Bo Li; Nicola J Rose; Edward T Mee; Deborah Smith; Mark Page; Martin P Cranage; Neil Almond; Greg J Towers; Neil J Berry
Journal:  PLoS One       Date:  2014-08-27       Impact factor: 3.240

10.  Characterization of CD8+ T cell differentiation following SIVΔnef vaccination by transcription factor expression profiling.

Authors:  James M Billingsley; Premeela A Rajakumar; Michelle A Connole; Nadine C Salisch; Sama Adnan; Yury V Kuzmichev; Henoch S Hong; R Keith Reeves; Hyung-joo Kang; Wenjun Li; Qingsheng Li; Ashley T Haase; R Paul Johnson
Journal:  PLoS Pathog       Date:  2015-03-13       Impact factor: 6.823

View more
  1 in total

Review 1.  Humanized Mice for Live-Attenuated Vaccine Research: From Unmet Potential to New Promises.

Authors:  Aoife K O'Connell; Florian Douam
Journal:  Vaccines (Basel)       Date:  2020-01-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.